Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMSQODK)

Drug Name
US8614253, 32-5 Drug Info
Synonyms SCHEMBL12767163; CHEMBL3639639; BDBM111369; US8614253, 32-5
Cross-matching ID
PubChem CID
59599919
TTD Drug ID
DMSQODK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Endoplasmic reticulum to nucleus signaling 1 (ERN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ORIN1001 DM27RXS Metastatic breast cancer 2C6Y Phase 1/2 [2]
US9040714, 7 DM53Z4I N. A. N. A. Patented [3]
T8361 DM86BDS N. A. N. A. Patented [1]
US8614253, 29-1 DMJKFVU N. A. N. A. Patented [4]
US8614253, 29-19 DMVI83P N. A. N. A. Patented [5]
879325-11-8 DMP04Z6 N. A. N. A. Patented [3]
AC1LE05K DMPOR3G N. A. N. A. Patented [6]
US8614253, 32-4 DMRSP2M N. A. N. A. Patented [5]
BB 0223767 DM2DT6L N. A. N. A. Patented [1]
US9241942, 32-12 DM8GW54 N. A. N. A. Patented [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Endoplasmic reticulum to nucleus signaling 1 (ERN1) TTOJ9QL ERN1_HUMAN Inhibitor [1]

References

1 IRE-1 inhibitors. US8614253.
2 Clinical pipeline report, company report or official report of Orinove.
3 IRE-1 inhibitors. US9040714.
4 IRE-1 inhibitors. US9241942.
5 IRE-1 inhibitors. US9493435.
6 IRE-1 inhibitors. US9693992.